Phase 1b Trial of TLR8 Agonist VTX-2337 in Combination With Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Authors :: Laura Q.M. Chow
Renato G. Martins
K. Manjarrez
Bernardo H. L. Goulart
Robert M. Hershberg
G. Dietsch
Chihiro Morishima
Christina S. Baik
Keith D. Eaton
Mary L. Disis
Source :: International Journal of Radiation Oncology*Biology*Physics. 88:503-504
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
Cetuximab
business.industry
Cell
medicine.anatomical_structure
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
In patient
TLR8 Agonist VTX-2337
business
Head and neck
medicine.drug

Tools